Our data indicate that the frequency of SF IL-17A+CD8+ (Tc17) T cells in patients with early SpA, including both PsA and peripheral SpA, is significantly increased compared with the seronegative UIA group and numerically increased compared with the smaller seropositive RA group. This evidence concerns the gene IL17A and rheumatoid arthritis.